Skip to main content

Table 3 Adjudicated hospitalization events in the PACE study

From: Rationale and design for the Predictors of Arrhythmic and Cardiovascular Risk in End Stage Renal Disease (PACE) study

Event Adjudicated based on following clinical criteria
Cardiovascular disease (CVD)  
Myocardial infarction Clinical symptoms Jaw pain or chest Pain
ECG markers Major Q wave
ST elevation with or without Q wave
Cardiac biomarkers Troponin I
CK-MB or CK total
Congestive heart failure/Volume overload Clinical symptoms Dyspnea on exertion or rest
Pulmonary edema or pulmonary congestion
Radiographic evidence Inspiratory crackles
S3 gallop
Physical exam Jugular venous distension
Peripheral edema
Procedures Atherosclerotic CVD (ASCVD) Percutaneous transluminal coronary angioplasty (PTCA)
Coronary artery bypass graft (CABG)
Carotid endarterectomy
Abdominal aortic aneurysm repair
Peripheral vascular disease (PVD) Peripheral angioplasty
Peripheral bypass
Limb amputation
Cerebrovascular Accident (CVA) clinical and supportive CT and MRI evidence Large artery stenosis >50% stenosis of major artery
Cerebral cortical impairment
Brainstem/cerebellar dysfunction
Cardioembolism  
Small-artery occlusion (lacunar) Clinical lacunar syndromes
No evidence of cortical dysfunction
Other etiology Nonatherosclerotic vasculopathies
Hypercoagulable states or hematologic disorders
Undetermined etiology
Systemic infections Sepsis Central Nervous system Access -related
Respiratory/GI tract Fungal Skin
Peritonitis Septic Arthritis Osteomyelitis
Fractures All Traumatic
Hip/ Vertebral compression Traumatic